653 related articles for article (PubMed ID: 22182219)
1. The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds.
Percival SL; Thomas J; Linton S; Okel T; Corum L; Slone W
Int Wound J; 2012 Oct; 9(5):488-93. PubMed ID: 22182219
[TBL] [Abstract][Full Text] [Related]
2. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates.
Percival SL; Slone W; Linton S; Okel T; Corum L; Thomas JG
Int Wound J; 2011 Jun; 8(3):237-43. PubMed ID: 21470369
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the antimicrobial efficacy of two silver-containing wound dressings on burn wound isolates.
Thomas JG; Slone W; Linton S; Corum L; Percival SL
J Wound Care; 2011 Dec; 20(12):580-2, 584-6. PubMed ID: 22240884
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial efficacy of a silver alginate dressing on burn wound isolates.
Thomas JG; Slone W; Linton S; Okel T; Corum L; Percival SL
J Wound Care; 2011 Mar; 20(3):124,126-8. PubMed ID: 21537295
[TBL] [Abstract][Full Text] [Related]
5. The Effect of pH on the Antimicrobial Efficiency of Silver Alginate on Chronic Wound Isolates.
Slone W; Linton S; Okel T; Corum L; Thomas JG; Percival SL
J Am Col Certif Wound Spec; 2010 Dec; 2(4):86-90. PubMed ID: 24527156
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of multidrug-resistant organisms recovered at a military burn center.
Keen EF; Robinson BJ; Hospenthal DR; Aldous WK; Wolf SE; Chung KK; Murray CK
Burns; 2010 Sep; 36(6):819-25. PubMed ID: 20080354
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of silver dressings and antibiotics on MRSA and MSSA isolated from burn patients.
Percival SL; Thomas JG; Slone W; Linton S; Corum L; Okel T
Wound Repair Regen; 2011 Nov; 19(6):767-74. PubMed ID: 22092847
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
9. Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986-2005).
Guggenheim M; Zbinden R; Handschin AE; Gohritz A; Altintas MA; Giovanoli P
Burns; 2009 Jun; 35(4):553-60. PubMed ID: 19167827
[TBL] [Abstract][Full Text] [Related]
10. In-vitro Activity of Honey and Topical Silver in Wound Care Management.
Wang YL; Yu QH; Chen SK; Wang YH
Drug Res (Stuttg); 2015 Nov; 65(11):592-6. PubMed ID: 25504003
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant organisms, wounds and topical antimicrobial protection.
Bowler PG; Welsby S; Towers V; Booth R; Hogarth A; Rowlands V; Joseph A; Jones SA
Int Wound J; 2012 Aug; 9(4):387-96. PubMed ID: 22640181
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activities of silver dressings: an in vitro comparison.
Ip M; Lui SL; Poon VKM; Lung I; Burd A
J Med Microbiol; 2006 Jan; 55(Pt 1):59-63. PubMed ID: 16388031
[TBL] [Abstract][Full Text] [Related]
14. The antimicrobial spectrum of Xeroform
Barillo DJ; Barillo AR; Korn S; Lam K; Attar PS
Burns; 2017 Sep; 43(6):1189-1194. PubMed ID: 28641915
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model.
Percival SL; Bowler PG; Dolman J
Int Wound J; 2007 Jun; 4(2):186-91. PubMed ID: 17651233
[TBL] [Abstract][Full Text] [Related]
17. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
18. The visualisation and speed of kill of wound isolates on a silver alginate dressing.
Hooper SJ; Percival SL; Hill KE; Thomas DW; Hayes AJ; Williams DW
Int Wound J; 2012 Dec; 9(6):633-42. PubMed ID: 22405034
[TBL] [Abstract][Full Text] [Related]
19. Microbicidal properties of a silver-containing hydrofiber dressing against a variety of burn wound pathogens.
Bowler PG; Jones SA; Walker M; Parsons D
J Burn Care Rehabil; 2004; 25(2):192-6. PubMed ID: 15091147
[TBL] [Abstract][Full Text] [Related]
20. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
